Plasmid pORF-hTRAIL targeting to glioma using transferrin-modified polyamidoamine dendrimer

References

• SiegelinMDGaiserTHabelADaidzein overcomes TRAIL-resistance in malignant glioma cells by modulating the expression of the intrinsic apoptotic inhibitor, bcl-2Neurosci Lett2009454322322819429088
   PubMed Web of Science ®Google Scholar
• RichJNBignerDDDevelopment of novel targeted therapies in the treatment of malignant gliomaNat Rev Drug Discov20043543044615136790
   PubMed Web of Science ®Google Scholar
• GieseAGlioma invasion–pattern of dissemination by mechanisms of invasion and surgical intervention, pattern of gene expression and its regulatory control by tumorsuppressor p53 and proto-oncogene ETS-1Acta Neurochir Suppl20038815316214531573
   PubMedGoogle Scholar
• LefrancFBrotchiJKissRPossible future issues in the treatment of glioblastomas: special emphasis on cell migration and the resistance of migrating glioblastoma cells to apoptosisJ Clin Oncol200523102411242215800333
   PubMed Web of Science ®Google Scholar
• DeAngelisLMBenefits of adjuvant chemotherapy in high-grade gliomasSemin Oncol2003306 Suppl 19151814765379
   PubMed Web of Science ®Google Scholar
• OldenhuisCNStegehuisJHWalenkampAMTargeting TRAIL death receptorsCurr Opin Pharmacol20088443343918625341
   PubMed Web of Science ®Google Scholar
• RiegerJNaumannUGlaserTAPO2 ligand: a novel lethal weapon against malignant glioma?FEBS Lett199842711241289613612
   PubMed Web of Science ®Google Scholar
• KeaneMMEttenbergSANauMMChemotherapy augments TRAIL-induced apoptosis in breast cell linesCancer Res19995937347419973225
   PubMed Web of Science ®Google Scholar
• PanGO’RourkeKChinnaiyanAMThe receptor for the cytotoxic ligand TRAILScience199727653091111139082980
   PubMed Web of Science ®Google Scholar
• HawkinsCJTRAIL and malignant gliomaVitam Horm20046742745215110189
   PubMed Web of Science ®Google Scholar
• RothWIsenmannSNaumannULocoregional Apo2L/TRAIL eradicates intracranial human malignant glioma xenografts in athymic mice in the absence of neurotoxicityBiochem Biophys Res Commun1999265247948310558893
   PubMed Web of Science ®Google Scholar
• FukumuraDXuLChenYHypoxia and acidosis independently up-regulate vascular endothelial growth factor transcription in brain tumors in vivoCancer Res200161166020602411507045
   PubMed Web of Science ®Google Scholar
• HobbsSKMonskyWLYuanFRegulation of transport pathways in tumor vessels: role of tumor type and microenvironmentProc Natl Acad Sci U S A1998958460746129539785
   PubMed Web of Science ®Google Scholar
• MonskyWLFukumuraDGohongiTAugmentation of transvascular transport of macromolecules and nanoparticles in tumors using vascular endothelial growth factorCancer Res199959164129413510463618
   PubMed Web of Science ®Google Scholar
• PardridgeWGene targeting technology and gene therapy of the brainDrug Discov Today20016312512611165183
   PubMed Web of Science ®Google Scholar
• PardridgeWMDrug and gene delivery to the brain: the vascular routeNeuron200236455555812441045
   PubMed Web of Science ®Google Scholar
• NewtonHBAdvances in strategies to improve drug delivery to brain tumorsExpert Rev Neurother20066101495150917078789
   PubMedGoogle Scholar
• GroothuisDRThe blood-brain and blood-tumor barriers: a review of strategies for increasing drug deliveryNeuro Oncol200021455911302254
   PubMed Web of Science ®Google Scholar
• QianZMLiHSunHTargeted drug delivery via the transferrin receptor-mediated endocytosis pathwayPharmacol Rev200254456158712429868
   PubMed Web of Science ®Google Scholar
• HatakeyamaHAkitaHMaruyamaKFactors governing the in vivo tissue uptake of transferrin-coupled polyethylene glycol liposomes in vivoInt J Pharm20042811–2253315288340
   PubMed Web of Science ®Google Scholar
• PenichetMLKangYSPardridgeWMAn antibody-avidin fusion protein specific for the transferrin receptor serves as a delivery vehicle for effective brain targeting: initial applications in anti-HIV antisense drug delivery to the brainJ Immunol199916384421442610510383
   PubMed Web of Science ®Google Scholar
• JefferiesWABrandonMRHuntSVTransferrin receptor on endothelium of brain capillariesNature198431259901621636095085
   PubMed Web of Science ®Google Scholar
• TortorellaSKaragiannisTCTransferrin receptor-mediated endocytosis: a useful target for cancer therapyJ Membr Biol2014247429130724573305
   PubMed Web of Science ®Google Scholar
• DixitSNovakTMillerKTransferrin receptor-targeted theranostic gold nanoparticles for photosensitizer delivery in brain tumorsNanoscale2015751782179025519743
   PubMed Web of Science ®Google Scholar
• BielinskaAUChenCJohnsonJDNA complexing with polyamidoamine dendrimers: implications for transfectionBioconjug Chem199910584385010502352
   PubMed Web of Science ®Google Scholar
• HuangRQQuYHKeWLEfficient gene delivery targeted to the brain using a transferrin-conjugated polyethyleneglycol-modified polyamidoamine dendrimerFASEB J20072141117112517218540
   PubMed Web of Science ®Google Scholar
• PangZGaoHYuYEnhanced intracellular delivery and chemotherapy for glioma rats by transferrin-conjugated biodegradable polymersomes loaded with doxorubicinBioconjug Chem20112261171118021528923
   PubMed Web of Science ®Google Scholar
• LvQLiLMHanMCharacteristics of sequential targeting of brain glioma for transferrin-modified cisplatin liposomeInt J Pharm20134441–21923347891
   PubMedGoogle Scholar
• ZhanCGuBXieCCyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effectJ Control Release2010143113614220056123
   PubMed Web of Science ®Google Scholar
• LiJGuoYKuangYCholine transporter-targeting and co-delivery system for glioma therapyBiomaterials201334369142914823993342
   PubMed Web of Science ®Google Scholar
• AvgeropoulosNGBatchelorTTNew treatment strategies for malignant gliomasOncologist19994320922410394589
   PubMedGoogle Scholar
• LuWSunQWanJCationic albumin-conjugated pegylated nanoparticles allow gene delivery into brain tumors via intravenous administrationCancer Res20066624118781188717178885
   PubMed Web of Science ®Google Scholar
• HanLHuangRLiJPlasmid pORF-hTRAIL and doxorubicin co-delivery targeting to tumor using peptide-conjugated polyamidoamine dendrimerBiomaterials20113241242125220971503
   PubMed Web of Science ®Google Scholar
• HuangSLiJHanLDual targeting effect of Angiopep-2-modified, DNA-loaded nanoparticles for gliomaBiomaterials201132286832683821700333
   PubMed Web of Science ®Google Scholar
• MohsenikiaMAlizadehAMKhodayariSThe protective and therapeutic effects of alpha-solanine on mice breast cancerEur J Pharmacol20137181–31924051269
   PubMed Web of Science ®Google Scholar
• TortorellaSKaragiannisTCThe significance of transferrin receptors in oncology: the development of functional nano-based drug delivery systemsCurr Drug Deliv201411442744324387131
   PubMed Web of Science ®Google Scholar
• NahaPCDavorenMLyngFMReactive oxygen species (ROS) induced cytokine production and cytotoxicity of PAMAM dendrimers in J774A.1 cellsToxicol Appl Pharmacol20102461–2919920420846
   PubMed Web of Science ®Google Scholar
• NahaPCDavorenMCaseyAAn ecotoxicological study of poly(amidoamine) dendrimers-toward quantitative structure activity relationshipsEnviron Sci Technol200943176864686919764261
   PubMed Web of Science ®Google Scholar
• NahaPCByrneHJGeneration of intracellular reactive oxygen species and genotoxicity effect to exposure of nanosized polyamidoamine (PAMAM) dendrimers in PLHC-1 cells in vitroAquat Toxicol2013132–1336172
   PubMed Web of Science ®Google Scholar
• MaherMANahaPCMukherjeeSPNumerical simulations of in vitro nanoparticle toxicity – the case of poly(amido amine) dendrimersToxicol In Vitro20142881449146025151936
   PubMed Web of Science ®Google Scholar
• Brannon-PeppasLBlanchetteJONanoparticle and targeted systems for cancer therapyAdv Drug Deliv Rev200456111649165915350294
   PubMed Web of Science ®Google Scholar
• TolcherAWGersonSLDenisLMarked inactivation of O6-alkylguanine-DNA alkyltransferase activity with protracted temozolomide schedulesBr J Cancer20038871004101112671695
   PubMed Web of Science ®Google Scholar